Gastrointestinal effects of low-digestible carbohydrates - PubMed (original) (raw)
Review
Gastrointestinal effects of low-digestible carbohydrates
Hollie A Grabitske et al. Crit Rev Food Sci Nutr. 2009 Apr.
Abstract
Low-digestible carbohydrates (LDCs) are carbohydrates that are incompletely or not absorbed in the small intestine but are at least partly fermented by bacteria in the large intestine. Fiber, resistant starch, and sugar alcohols are types of LDCs. Given potential health benefits (including a reduced caloric content, reduced or no effect on blood glucose levels, non-cariogenic effect) the prevalence of LDCs in processed foods is increasing. Many of the benefits of LDCs are related to the inability of human digestive enzymes to break down completely the carbohydrates into absorbable saccharides and the subsequent fermentation of unabsorbed carbohydrates in the colon. As a result, LDCs may affect laxation and cause gastrointestinal effects, including abdominal discomfort, flatus, and diarrhea, especially at higher or excessive intakes. Such responses, though transient, affect the perception of the well-being of consumers and their acceptance of food products containing LDCs. Current recommendations for fiber intake do not consider total LDC consumption nor recommend an upper limit for LDC intake based on potential gastrointestinal effects. Therefore, a review of published studies reporting gastrointestinal effects of LDCs was conducted. We included only studies published in refereed journals in English. Additionally, we excluded studies of subjects with incomplete or abnormal functioning gastrointestinal tracts or where antibiotics, stimulant laxatives, or other drugs affecting motility were included. Only in studies with a control period, either placebo treatment or no LDC treatment, were included. Studies must have included an acceptable measure of gastrointestinal effect. Sixty-eight studies and six review articles were evaluated. This review describes definitions, classifications, and mechanisms of LDCs, evaluates published human feeding studies of fifteen LDCs for associations between gastrointestinal effects and levels of LDC intake, and presents recommendations for LDC consumption and further research.
Similar articles
- Low-digestible carbohydrates in practice.
Grabitske HA, Slavin JL. Grabitske HA, et al. J Am Diet Assoc. 2008 Oct;108(10):1677-81. doi: 10.1016/j.jada.2008.07.010. J Am Diet Assoc. 2008. PMID: 18926133 Review. - Tolerance to low-digestible carbohydrates: symptomatology and methods.
Marteau P, Flourié B. Marteau P, et al. Br J Nutr. 2001 Mar;85 Suppl 1:S17-21. doi: 10.1079/bjn2000258. Br J Nutr. 2001. PMID: 11321024 Review. - Tolerance of low-digestible carbohydrates: a general view.
Livesey G. Livesey G. Br J Nutr. 2001 Mar;85 Suppl 1:S7-16. doi: 10.1079/bjn2000257. Br J Nutr. 2001. PMID: 11321031 Review. - Non-polyol low-digestible carbohydrates: food applications and functional benefits.
Murphy O. Murphy O. Br J Nutr. 2001 Mar;85 Suppl 1:S47-53. doi: 10.1079/bjn2000261. Br J Nutr. 2001. PMID: 11321026 Review. - Energy value of a low-digestible carbohydrate, NUTRIOSE FB, and its impact on magnesium, calcium and zinc apparent absorption and retention in healthy young men.
Vermorel M, Coudray C, Wils D, Sinaud S, Tressol JC, Montaurier C, Vernet J, Brandolini M, Bouteloup-Demange C, Rayssiguier Y. Vermorel M, et al. Eur J Nutr. 2004 Dec;43(6):344-52. doi: 10.1007/s00394-004-0477-z. Epub 2004 Jan 26. Eur J Nutr. 2004. PMID: 15309452 Clinical Trial.
Cited by
- Adaptation to tolerate high doses of arabinoxylan is associated with fecal levels of Bifidobacterium longum.
Deehan EC, Zhang Z, Nguyen NK, Perez-Muñoz ME, Cole J, Riva A, Berry D, Prado CM, Walter J. Deehan EC, et al. Gut Microbes. 2024 Jan-Dec;16(1):2363021. doi: 10.1080/19490976.2024.2363021. Epub 2024 Jun 11. Gut Microbes. 2024. PMID: 38860973 Free PMC article. Clinical Trial. - Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity.
Then CK, Paillas S, Moomin A, Misheva MD, Moir RA, Hay SM, Bremner D, Roberts Nee Nellany KS, Smith EE, Heidari Z, Sescu D, Wang X, Suárez-Bonnet A, Hay N, Murdoch SL, Saito R, Collie-Duguid ESR, Richardson S, Priestnall SL, Wilson JM, Gurumurthy M, Royle JS, Samuel LM, Ramsay G, Vallis KA, Foster KR, McCullagh JSO, Kiltie AE. Then CK, et al. Microbiome. 2024 May 14;12(1):89. doi: 10.1186/s40168-024-01804-1. Microbiome. 2024. PMID: 38745230 Free PMC article. - Acute and two-week effects of neotame, stevia rebaudioside M and sucrose-sweetened biscuits on postprandial appetite and endocrine response in adults with overweight/obesity-a randomised crossover trial from the SWEET consortium.
Gibbons C, Beaulieu K, Almiron-Roig E, Navas-Carretero S, Martínez JA, O'Hara B, O'Connor D, Nazare JA, Le Bail A, Rannou C, Hardman C, Wilton M, Kjølbæk L, Scott C, Moshoyiannis H, Raben A, Harrold JA, Halford JCG, Finlayson G. Gibbons C, et al. EBioMedicine. 2024 Apr;102:105005. doi: 10.1016/j.ebiom.2024.105005. Epub 2024 Mar 28. EBioMedicine. 2024. PMID: 38553262 Free PMC article. Clinical Trial. - Dichotomous effect of dietary fiber in pediatrics: a narrative review of the health benefits and tolerance of fiber.
Basuray N, Deehan EC, Vieira FT, Avedzi HM, Duke RL, Colín-Ramírez E, Tun HM, Zhang Z, Wine E, Madsen KL, Field CJ, Haqq AM. Basuray N, et al. Eur J Clin Nutr. 2024 Jul;78(7):557-568. doi: 10.1038/s41430-024-01429-5. Epub 2024 Mar 13. Eur J Clin Nutr. 2024. PMID: 38480843 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous